Green Cross has targeted the Latin America with its blood fractionation product when its final goal is the U.S.
Green Cross (CEO Eun-cheol Huh) announced on the 4th that the company won an order to supply Immunoglobulin IV Globulin S (IVIG-SN) worth of $ 5.72 million on the recent Brazilian governmental pharmaceutical bidding.
The amount of the order was increased by 33% from the amount of the last order ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
